Sort
261,768 grants matching “gene therapy”
North and Central Texas Clinical and Translational Science Initiative (KL2)
$1,065,555Milton Packer · Ut Southwestern Medical Center · KL2 · FY2009 · RR
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,065,423Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$1,065,405Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
RNAi Screening in Hematopoietic Cells
$1,065,285Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Analysis of Innate Immune Signaling Networks
$1,065,285Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,065,252Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Chromatin Remodeling and Gene Activation
$1,065,073David J Clark · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Cellular Strategies for Tolerance Induction
$1,064,930Andrew B Adams · Emory University · U19 · FY2019 · AI
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease
$1,064,794Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · P30 · FY2009 · DK
Nanotechnology Targeting Novel CD154:CD11b Interactions for Transplant Tolerance
$1,064,643Mandy L. Ford · University Of Minnesota · U19 · FY2023 · AI
Time Domian Electron Paramagnetic Resonance Imaging
$1,064,634Murali Cherukuri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
NIDCD Core for Clinical Research and Care
$1,064,633Carter Van Waes · National Institute On Deafness And Other Communication Disorders · Z01 · FY2008 · DC
Novel Therapy for Wet Age-Related Macular Degeneration
$1,064,532Advanced Vision Therapies, Inc. · R44 · FY2005 · EY
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,064,486Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Genetic susceptibility and common multi-factorial retinal/macular diseases
$1,064,372Anand Swaroop · National Eye Institute · ZIA · FY2014 · EY
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
$1,064,328Steven M Kawut · University Of Pennsylvania · R01 · FY2021 · HL
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,064,245Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2025 · CA
Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate Cancer
$1,063,904Akash Patnaik · University Of Chicago · R01 · FY2025 · CA
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,063,812Duke University · P50 · FY2000 · NS
Center for Gene Therapy of Cystic Fibrosis and Other Ge*
$1,063,674University Of Iowa · P30 · FY2004 · DK
Center for Gene Therapy of Cystic Fibrosis and Other Ge*
$1,063,674University Of Iowa · P30 · FY2003 · DK
Center for Gene Therapy of Cystic Fibrosis and Other Ge*
$1,063,674University Of Iowa · P30 · FY2005 · DK
PEARL: Pathway Exploration and Analysis in Renal Lupus
$1,063,616Betty Diamond · Feinstein Institute For Medical Research · UH2 · FY2020 · AR
GSK3b mediates convergence of protection signaling to limit mitochondrial damage
$1,063,460Steven Sollott · National Institute On Aging · ZIA · FY2012 · AG
Interventional approaches for restoring vision
$1,063,252Anand Swaroop · National Eye Institute · ZIA · FY2017 · EY